Weighted Average Number of Shares Outstanding, Basic of ABVC BIOPHARMA, INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ABVC BIOPHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • ABVC BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 20,108,944, a 72% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 20,108,944, a 72% increase from 2024.
  • ABVC BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 11,673,980, a 169% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4,335,650, a 37% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 20,108,944 +8,434,964 +72% 01 Oct 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 23,256,590 +10,851,329 +87% 01 Jul 2025 30 Sep 2025 10-Q/A 03 Mar 2026 2025 Q3
Q2 2025 17,386,536 +6,065,259 +54% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 14,968,232 +5,232,082 +54% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 11,673,980 +7,338,330 +169% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 12,405,261 +8,349,916 +206% 01 Jul 2024 30 Sep 2024 10-Q/A 03 Mar 2026 2025 Q3
Q2 2024 11,321,277 +8,012,537 +242% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 9,736,150 +6,428,573 +194% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 4,335,650 +1,169,190 +37% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 4,055,345 +797,433 +24% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 3,308,740 +178,007 +5.7% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 3,307,577 -26,375,825 -89% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024 2024 Q1
Q4 2022 3,166,460 -21,887,062 -87% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 3,257,912 -23,624,269 -88% 01 Jul 2022 30 Sep 2022 10-Q 15 Nov 2023 2023 Q3
Q2 2022 3,130,733 -21,290,349 -87% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 29,683,402 +5,262,876 +22% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 25,053,522 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 26,882,181 +7,394,013 +38% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 24,421,082 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 24,420,526 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 19,488,168 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2019 17,422,988 +5,813,531 +50% 01 Apr 2019 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 14,965,665 +3,365,754 +29% 01 Jan 2019 31 Mar 2019 10-Q 28 May 2019 2019 Q1
Q4 2018 213,884,105 +137,458 +0.06% 01 Oct 2018 31 Dec 2018 10-K 15 Apr 2019 2018 FY
Q3 2018 213,926,475 +179,828 +0.08% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 11,609,457 -202,137,190 -95% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 11,599,911 -200,456,736 -95% 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019 2019 Q1
Q4 2017 213,746,647 +2,925,000 +1.4% 01 Oct 2017 31 Dec 2017 10-KT 13 Apr 2018 2017 FY
Q3 2017 213,746,647 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 213,746,647 01 Apr 2017 30 Jun 2017 10-Q 20 Aug 2018 2018 Q2
Q1 2017 212,056,647 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 210,821,647 +46,940,448 +29% 01 Oct 2016 31 Dec 2016 10-Q/A 19 Mar 2018 2017 Q1
Q4 2015 163,881,199 +109,288,167 +200% 01 Oct 2015 31 Dec 2015 10-Q/A 19 Mar 2018 2017 Q1
Q3 2015 160,823,831 21 Jul 2015 30 Sep 2015 10-K 22 Feb 2017 2016 FY
Q4 2014 54,593,032 01 Oct 2014 31 Dec 2014 10-Q 23 Feb 2016 2016 Q1
Q2 2012 28,927,903 +18,269,397 +171% 01 Apr 2012 30 Jun 2012 10-Q/A 20 Aug 2012 2012 Q3
Q1 2012 16,331,882 +6,123,376 +60% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2012 2012 Q2
Q4 2011 16,138,232 +9,223,245 +133% 01 Oct 2011 31 Dec 2011 10-Q 21 Feb 2012 2012 Q1
Q3 2011 9,738,194 01 Jul 2011 30 Sep 2011 10-K/A 28 Dec 2011 2011 FY
Q2 2011 10,658,506 +4,076,369 +62% 01 Apr 2011 30 Jun 2011 10-Q/A 20 Aug 2012 2012 Q3
Q1 2011 10,208,506 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q2
Q4 2010 6,914,987 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012 2012 Q1
Q2 2010 6,582,137 01 Apr 2010 30 Jun 2010 10-Q/A 08 Sep 2011 2011 Q3

ABVC BIOPHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 20,108,944 +8,434,964 +72% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 11,673,980 +7,338,330 +169% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 4,335,650 +1,169,190 +37% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 3,166,460 -21,887,062 -87% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 25,053,522 +5,337,963 +27% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 19,715,559 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2018 213,884,105 +562,184 +0.26% 01 Jan 2018 31 Dec 2018 10-K 15 Apr 2019 2018 FY
2017 213,321,921 +19,340,768 +10% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019 2018 FY
2016 193,981,153 +188,980,224 +3779% 01 Oct 2015 30 Sep 2016 10-KT 13 Apr 2018 2017 FY
2015 5,000,929 +4,989,785 01 Oct 2014 30 Sep 2015 10-K 27 Nov 2015 2015 FY
2014 11,144* 01 Oct 2013 30 Sep 2014 10-K 27 Nov 2015 2015 FY
2011 9,738,194 +3,156,057 +48% 01 Oct 2010 30 Sep 2011 10-K/A 28 Dec 2011 2011 FY
2010 6,582,137 01 Oct 2009 30 Sep 2010 10-K/A 28 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.